# Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study

> **NCT07173374** · PHASE1 · SUSPENDED · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 24 (estimated)

## Conditions studied

- Pancreatic Cancer
- Locally Advanced Pancreatic Cancer

## Interventions

- **RADIATION:** SCART Dose Escalation Arm

## Key facts

- **NCT ID:** NCT07173374
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-09-10
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 24 (ESTIMATED)
- **Why stopped:** The study was terminated early due to slow patient accrual. Enrollment was substantially lower than anticipated, making it unlikely to achieve the planned sample size within a reasonable timeframe.
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173374, "Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07173374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*